Clinic Consulting Electronics Manufacturing 
FDA Law Blog
NOVEMBER 20, 2024
Chemical characterization can also be useful in evaluating a change to the materials or manufacturing of a device. FDA suggests that simulated use/leachables studies to simulate the clinical use (i.e., By Adrienne R. In the draft guidance, FDA illustrates the need for additional orthogonal data (i.e.,
FDA Law Blog
JULY 7, 2024
Laboratories struggling to understand the myriad implications of being regulated as device “manufacturers” were hopeful that additional guidance would shed light on how to apply FDA’s existing medical device regulatory framework to their operations. 803), Reporting of Corrections and Removals (21 C.F.R. § 806) and Complaint Files (21 C.F.R.
FDA Law Blog
JANUARY 8, 2023
The Act requires DEA, in consultation with HHS, to assess annually whether an adequate and uninterrupted supply, down to specific strains, exists and to establish sufficient quotas to ensure an uninterrupted supply. Cannabis Manufacturer Registration for Research. Adequate and Uninterrupted Supply of Cannabis. Application Process.
Expert insights. Personalized for you.
59 
Let's personalize your content